Stryker Corporation $SYK Shares Acquired by Brown Miller Wealth Management LLC

Brown Miller Wealth Management LLC lifted its position in Stryker Corporation (NYSE:SYK) by 0.4% during the second quarter, HoldingsChannel.com reports. The fund owned 7,416 shares of the medical technology company’s stock after acquiring an additional 29 shares during the period. Stryker makes up 0.9% of Brown Miller Wealth Management LLC’s portfolio, making the stock its 26th largest position. Brown Miller Wealth Management LLC’s holdings in Stryker were worth $2,934,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Mogy Joel R Investment Counsel Inc. lifted its stake in shares of Stryker by 3.4% in the first quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company’s stock worth $36,561,000 after buying an additional 3,218 shares in the last quarter. Ferguson Wellman Capital Management Inc. raised its holdings in Stryker by 1.9% in the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company’s stock valued at $65,096,000 after acquiring an additional 3,341 shares during the last quarter. Harbor Capital Advisors Inc. purchased a new position in Stryker in the 1st quarter worth approximately $1,840,000. Mar Vista Investment Partners LLC boosted its holdings in shares of Stryker by 10.2% during the 1st quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company’s stock worth $33,572,000 after purchasing an additional 8,353 shares during the last quarter. Finally, United Services Automobile Association purchased a new stake in shares of Stryker in the first quarter valued at approximately $2,857,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Viju Menon sold 500 shares of the firm’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the transaction, the director owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

SYK has been the topic of a number of recent research reports. Rothschild & Co Redburn began coverage on Stryker in a research note on Thursday, September 18th. They set a “neutral” rating and a $420.00 price objective on the stock. Wells Fargo & Company boosted their price target on shares of Stryker from $435.00 to $445.00 and gave the company an “overweight” rating in a research report on Friday, August 1st. Rothschild Redb upgraded shares of Stryker to a “hold” rating in a research report on Thursday, September 18th. Evercore ISI lifted their target price on shares of Stryker from $390.00 to $415.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 8th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Stryker in a research note on Saturday, September 27th. Fifteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $430.33.

Stryker Stock Performance

NYSE:SYK opened at $370.59 on Friday. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The company has a 50 day moving average price of $382.81 and a 200 day moving average price of $378.93. The stock has a market capitalization of $141.68 billion, a P/E ratio of 49.08, a PEG ratio of 2.67 and a beta of 0.94.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, topping analysts’ consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $5.92 billion. During the same period in the prior year, the firm earned $2.81 earnings per share. The firm’s revenue was up 11.1% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Equities research analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. Stryker’s dividend payout ratio is 44.50%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.